Can Benlioglu

Can Benlioglu

Auto-generated profile, based on publicly available information

Can Benlioglu

Research Center for Translational Medicine, Koç University , Istanbul

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in eClinicalMedicine
Verified
Journal Article
Open access
Asma KhalilAsma Khalil
Asma Khalil
EKErkan Kalafat
Erkan Kalafat
CBCan Benlioglu
Can Benlioglu
POPat O'BRien
Pat O'BRien
EMEdward Morris
Edward Morris
LMLaura A. Magee
Laura A. Magee
Perform a systematic review and meta-analysis of SARS-CoV-2 infection and pregnancy. Databases (Medline, Embase, Clinicaltrials.gov, Cochrane Library) were searched electronically on 6th April and updated regularly until 8th June 2020. Reports of pregnant women with reverse transcription PCR (RT-PCR) confirmed COVID-19 were included. Meta-analytical proportion summaries and meta-regression analyses for key clinical outcomes are provided. 86 studies were included, 17 studies (2567 pregnancies) in the quantitative synthesis; other small case series and case reports were used to extract rarely-reported events and outcome. Most women (73.9%) were in the third trimester; 52.4% have delivered, half by caesarean section (48.3%). The proportion of Black, Asian or minority ethnic group membership (50.8%); obesity (38.2%), and chronic co-morbidities (32.5%) were high. The most commonly reported clinical symptoms were fever (63.3%), cough (71.4%) and dyspnoea (34.4%). The commonest laboratory abnormalities were raised CRP or procalcitonin (54.0%), lymphopenia (34.2%) and elevated transaminases (16.0%). Preterm birth before 37 weeks’ gestation was common (21.8%), usually medically-indicated (18.4%). Maternal intensive care unit admission was required in 7.0%, with intubation in 3.4%. Maternal mortality was uncommon (~1%). Maternal intensive care admission was higher in cohorts with higher rates of co-morbidities (beta=0.007, p<0.05) and maternal age over 35 years (beta=0.007, p<0.01). Maternal mortality was higher in cohorts with higher rates of antiviral drug use (beta=0.03, p<0.001), likely due to residual confounding. Neonatal nasopharyngeal swab RT-PCR was positive in 1.4%. The risk of iatrogenic preterm birth and caesarean delivery was increased. The available evidence is reassuring, suggesting that maternal morbidity is similar to that of women of reproductive age. Vertical transmission of the virus probably occurs, albeit in a small proportion of cases. N/A

1 January 2020 in Pregnancy Hypertension
Verified
Journal Article
Closed access
EKErkan Kalafat
Erkan Kalafat
CBCan Benlioglu
Can Benlioglu
BTBasky Thilaganathan
Basky Thilaganathan
Asma KhalilAsma Khalil
Asma Khalil

19 September 2019 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
EKErkan Kalafat
Erkan Kalafat
AGAli Gokce
Ali Gokce
POPat O'Brien
Pat O'Brien
CBCan Benlioglu
Can Benlioglu
AKAcar Koc
Acar Koc
AKAsma Khalil
Asma Khalil
Objectives: To evaluate the efficacy of carbetocin for the prevention of postpartum hemorrhage (PPH) and related events after vaginal or cesarean delivery. Methods: Medline, Scopus, Embase, and the Cochrane Library were searched in February 2018 using combinations of the relevant MeSH terms, keywords. Bibliographies of articles were also subjected to manual search for additional reports. Randomized studies comparing carbetocin to any other uterotonic agent in the management of cesarean and vaginal deliveries. Two reviewers independently extracted the data. A random-effects meta-analysis was used for quantitative synthesis. Also, Bayesian random-effect metaregression was used to estimate the posterior probabilities (PP) for benefit with carbetocin use. Results: After full-text review, 30 trials were included in the meta-analysis. Compared to oxytocin, carbetocin was associated with a reduced need for additional uterotonic use in women undergoing cesarean delivery (RR 0.43, 95% CI 0.30–0.59, I^2 = 71%, 3216 women, PP > 99.9%). Women at high risk of PPH delivering vaginally also had a reduced need for additional uterotonic use with carbetocin compared to oxytocin (RR 0.56, 95% CI 0.34–0.94, I^2 = 38%, 789 women, PP = 81.2%). The risk of postpartum blood transfusion (RR 0.57, 95% CI 0.33–0.96, I^2 = 0%, 1991 women, PP = 97.9%) was also less with carbetocin compared to oxytocin in high-risk women undergoing cesarean delivery. The risk of PPH was similar between carbetocin and other uterotonic agents for both cesarean (RR 0.69, 95% CI 0.45–1.05, I^2 = 27%, 2926 women, PP = 96.3%) and vaginal deliveries (RR 0.61, 95% CI 0.32–1.14, I^2 = 35%, 1515 women, PP = 88.9%). Carbetocin is effective in reducing the need for additional uterotonic use and postpartum blood transfusion in high-risk women undergoing Cesarean delivery.

11 March 2020 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Closed access
PDF file
FDFrancesco D’aNtonio
Francesco D’aNtonio
CBCan Benlioglu
Can Benlioglu
FSFilomena Giulia Sileo
Filomena Giulia Sileo
BTBasky Thilaganathan
Basky Thilaganathan
APAris Papageorghiou
Aris Papageorghiou
Asma KhalilAsma Khalil
Asma Khalil

22 October 2021 in Yeni Üroloji Dergisi
Verified
Journal Article
Closed access
PDF file
CBCan Benli̇oğlu
Can Benli̇oğlu
AÇAli Çi̇ft
Ali Çi̇ft
Objective: In this study, we aimed to investigate the benefit of hematological results in determining the differential diagnosis between testicular torsion (TT) and epididymo-orchitis (EO) in patients presenting with acute scrotum, and to determine its predictive value for the diagnosis of TT. Material and Methods: We retrospectively analyzed 98 patients who applied to our institute’s urology clinics or emergency service with complaints of acute scrotum. Thirty-two patients who underwent orchiectomy or detorsion due to TT and 48 patients with EO were included in the study. The control group consisted of 80 healthy men. Groups were compared in terms of hematological parameters such as age, white blood cell (WBC), mean platelet volume (MPV), neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), and platelet/lymphocyte ratio (PLR). Results: WBC, MPV and NLR were found to be statistically significant in distinguishing TT group from other groups, respectively; (AUC = 0.732, 95% CI: 0.647-0.816 and p<0.001), (AUC = 0.720, 95% CI: 0.615-0.825 and p<0.001), (AUC = 0.629, 95% CI: 0.519-0.739 and p=0.024). In the comparison between the detorsion and orchiectomy subgroups within the TT group, the first had a statistically lower monocyte count (p=0.005) and MLR level (p=0.038). Conclusion: Hematological parameters; that is, WBC, MPV and NLR, which can be easily determined from complete blood count analysis, had high sensitivity and specificity similar to Doppler ultrasonography to predict TT. In addition, we think that monocyte and MLR levels may be beneficial in patients who have difficulty in the decision of orchiectomy or detorsion in TT surgery. Keywords: Acute scrotum, testicular torsion, epididymo-orchitis, mean platelet volume, neutrophil/lymphocyte ratio

7 March 2024 in Journal of the Turkish-German Gynecological Association
Verified
Journal Article
Open access
CBCan Benlioğlu
Can Benlioğlu
YAYunus Aydın
Yunus Aydın
MBMustafa Bahçeci
Mustafa Bahçeci
VBVolkan Baltacı
Volkan Baltacı
SKSibel Bulgurcuoglu Kuran
Sibel Bulgurcuoglu Kuran
BABarış Ata
Barış Ata
The aim of this study was to describe characteristics and outcomes of assisted reproductive technology (ART) cycles performed in 2019 in Turkey. One-hundred and sixty-five ART centers in Turkey were invited to submit data. The survey was sent to center directors via e-mail with anonymous links by Qualtrics™. The survey involved questions about their patient characteristics, clinical practices, and outcomes. Forty-one (24.8%) centers responded to e-mails, and data gathered from 25 centers was included in the analyses. In 25 centers, 18,127 fresh or frozen transfers were carried out during the study period, of which 7796 (43.0%) were fresh and the rest were either frozen (45.2%) or embryo transfers (ET) with preimplantation genetic testing (PGT) (11.8%). The live birth rate per ET was as 30.6%, 40.1%, and 50.7% in fresh, frozen and PGT cycles, respectively. A single embryo was transferred in 65.3% of all transfers and singleton live births comprised 86.1% of all deliveries. For cycles with intrauterine insemination, 1407 were started in 2019, and 195 clinical pregnancies, 150 live births with 19 multiple pregnancies occurred. A total of 1513 ART cycles were initiated for foreign patients. Russia (29.6%), Germany (7.4%), Iraq (4.6%), Uzbekistan (3.1%), and Syria (1.4%) were the top five countries with most patients coming to Turkey for ART. The survey results are in parallel with the reports of international institutions and organizations. With repeated editions, the data collected with annual surveys can be used to inform ART practices in the coming years.